by Philippa Shelton | May 30, 2022 | Press Releases
Wellmarker Bio signs MoU with Isogenica for the development of multiple therapeutic assets The MoU will serve as a foundation for increased cooperation between the two companies Wellmarker Bio (WMBIO) and Isogenica today announced the signing of a Memorandum of... by Mandeep Sehmi | Apr 25, 2022 | Press Releases
Isogenica-Phenotypeca Further Collaboration through Medilink Award Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Read the Press Release Isogenica are furthering their collaboration with Phenotypeca, whose platform will deploy... by Mandeep Sehmi | Mar 17, 2022 | Press Releases
Isogenica-Phenotypeca SMART Grant Collaboration Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Read the Press Release Isogenica are collaborating with Phenotypeca, a biofoundry business who create and own yeast synthetic biology solutions... by Harriet Boyd | Sep 9, 2021 | Press Releases, Welcome
Isogenica-PipeBio Collaboration Press Release Isogenica announce deployment of the PipeBio Bioinformatic Cloud Read the Press Release Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...
by Mandeep Sehmi | May 20, 2021 | Press Releases, Welcome
Isogenica announced today that Dr William (Bill) Eldridge has been promoted to Chief Scientific Officer. Since joining Isogenica as Senior Director of Antibody Alliances in January 2020, Dr Eldridge has played a leading role in delivering Isogenica’s multi-target... by Harriet Boyd | Jan 18, 2021 | Press Releases, Welcome
Isogenica multi-year multi-target collaboration with Aro Biotherapeutics extended Isogenica-Aro collaboration goes from strength to strength Read The Press Release Isogenica today announced the collaboration and license agreement signed with Aro Biotherapeutics in...